FDA To Revamp Regulatory Science Agenda
The U.S. Food and Drug Administration has unveiled a plan to bolster its efforts to advance regulatory science, including the development of new tools and standards for assessing the safety of...To view the full article, register now.
Already a subscriber? Click here to view full article